108 related articles for article (PubMed ID: 12950231)
21. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia.
Fülöp Z; Csernus B; Tímár B; Szepesi A; Matolcsy A
Leukemia; 2003 Feb; 17(2):411-5. PubMed ID: 12592341
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
23. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
[TBL] [Abstract][Full Text] [Related]
24. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J
Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986
[TBL] [Abstract][Full Text] [Related]
25. Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).
Leupin N; Cenni B; Novak U; Hügli B; Graber HU; Tobler A; Fey MF
Br J Haematol; 2003 Apr; 121(1):97-100. PubMed ID: 12670337
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
27. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
[No Abstract] [Full Text] [Related]
28. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Laake K; Odegård A; Andersen TI; Bukholm IK; Kåresen R; Nesland JM; Ottestad L; Shiloh Y; Børresen-Dale AL
Genes Chromosomes Cancer; 1997 Mar; 18(3):175-80. PubMed ID: 9071570
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
[TBL] [Abstract][Full Text] [Related]
31. Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.
Krieger D; Moericke A; Oschlies I; Zimmermann M; Schrappe M; Reiter A; Burkhardt B
Haematologica; 2010 Jan; 95(1):158-62. PubMed ID: 19586936
[TBL] [Abstract][Full Text] [Related]
32. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia.
Takeuchi S; Koike M; Park S; Seriu T; Bartram CR; Taub HE; Williamson IK; Grewal J; Taguchi H; Koeffler HP
Br J Haematol; 1998 Nov; 103(2):536-8. PubMed ID: 9827931
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Zenz T; Benner A; Döhner H; Stilgenbauer S
Cell Cycle; 2008 Dec; 7(24):3810-4. PubMed ID: 19098429
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
35. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
36. NS22: a highly polymorphic complex microsatellite marker within the ATM gene.
Udar N; Farzad S; Tai LQ; Bay JO; Gatti RA
Am J Med Genet; 1999 Feb; 82(4):287-9. PubMed ID: 10051159
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
38. Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.
Ouillette P; Fossum S; Parkin B; Ding L; Bockenstedt P; Al-Zoubi A; Shedden K; Malek SN
Clin Cancer Res; 2010 Feb; 16(3):835-47. PubMed ID: 20086003
[TBL] [Abstract][Full Text] [Related]
39. ATM mutations and protein expression are not associated with familial B-CLL cases.
Ishibe N; Goldin LR; Caporaso NE; Sgambati MT; Dean M; Albitar M; Manshouri T; Gerrard B; Marti GE
Leuk Res; 2003 Oct; 27(10):973-5. PubMed ID: 12860021
[No Abstract] [Full Text] [Related]
40. No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
Mikeska T; Carney DA; Seymour JF; Dobrovic A
Leuk Lymphoma; 2012 Jul; 53(7):1420-2. PubMed ID: 22204453
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
